Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP403690.RAeiLRUT91Us5cYwJ0Z0-YZLg2v7xq3c4IoYjuVz4d1yM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP403690.RAeiLRUT91Us5cYwJ0Z0-YZLg2v7xq3c4IoYjuVz4d1yM130_assertion type Assertion NP403690.RAeiLRUT91Us5cYwJ0Z0-YZLg2v7xq3c4IoYjuVz4d1yM130_head.
- NP403690.RAeiLRUT91Us5cYwJ0Z0-YZLg2v7xq3c4IoYjuVz4d1yM130_assertion description "[These results offer general import beyond prostate cancer, given that nuclear FHL2 is characteristic of other human cancers where oncogenic transcription factors that drive disease are activated like the AR in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP403690.RAeiLRUT91Us5cYwJ0Z0-YZLg2v7xq3c4IoYjuVz4d1yM130_provenance.
- NP403690.RAeiLRUT91Us5cYwJ0Z0-YZLg2v7xq3c4IoYjuVz4d1yM130_assertion evidence source_evidence_literature NP403690.RAeiLRUT91Us5cYwJ0Z0-YZLg2v7xq3c4IoYjuVz4d1yM130_provenance.
- NP403690.RAeiLRUT91Us5cYwJ0Z0-YZLg2v7xq3c4IoYjuVz4d1yM130_assertion SIO_000772 23801747 NP403690.RAeiLRUT91Us5cYwJ0Z0-YZLg2v7xq3c4IoYjuVz4d1yM130_provenance.
- NP403690.RAeiLRUT91Us5cYwJ0Z0-YZLg2v7xq3c4IoYjuVz4d1yM130_assertion wasDerivedFrom befree-20150227 NP403690.RAeiLRUT91Us5cYwJ0Z0-YZLg2v7xq3c4IoYjuVz4d1yM130_provenance.
- NP403690.RAeiLRUT91Us5cYwJ0Z0-YZLg2v7xq3c4IoYjuVz4d1yM130_assertion wasGeneratedBy ECO_0000203 NP403690.RAeiLRUT91Us5cYwJ0Z0-YZLg2v7xq3c4IoYjuVz4d1yM130_provenance.